Atlas Trials

A Study of Second-line Treatment With Apatinib in Patients With Advanced Intrahepatic Cholangiocarcinoma

Clinical trial NCT03251443 · COMPLETED

Trial details

NCT number
NCT03251443
Sponsor
Peking Union Medical College Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Intrahepatic CholangiocarcinomaSecond-line Treatment
Start date
2017-08-08
Primary completion
2019-03-08
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.